<DOC>
	<DOCNO>NCT02355522</DOCNO>
	<brief_summary>This randomize , double-blinded , double placebo-controlled trial . Patients undergoing saline infusion sonohysterography ( SIS ) recruit randomized three group receive ( ) 3ml 2 % lidocaine gel cervix 5ml intrauterine normal saline ; ( b ) 3ml KY jelly cervix 5ml 2 % intrauterine lidocaine ( c ) 3ml KY jelly cervix 5mL intrauterine normal saline prior SIS . Pain level record evaluate efficacy local lidocaine gel intrauterine lidocaine infusion reduce pain SIS .</brief_summary>
	<brief_title>Trial Local Lidocaine Gel Intrauterine Lidocaine Infusion Pain Relief During Saline Infusion Sonohysterography</brief_title>
	<detailed_description>Trial objective purpose : To evaluate efficacy local lidocaine gel intrauterine lidocaine infusion reduce pain saline infusion sonohysterography ( SIS ) . Trial design : This randomize , double-blinded , double placebo-controlled trial . Patients undergoing SIS recruit randomized three group receive ( ) 3ml 2 % lidocaine gel cervix 5ml intrauterine normal saline ; ( b ) 3ml KY jelly cervix 5ml 2 % intrauterine lidocaine ( c ) 3ml KY jelly cervix 5mL intrauterine normal saline prior SIS . Randomization Before procedure , patient randomize three group predetermine computer-generated randomization code prepare research nurse receive ( ) 3ml 2 % lidocaine gel cervix 5ml intrauterine normal saline ; ( b ) 3ml KY jelly cervix 5ml 2 % intrauterine lidocaine ( c ) 3ml KY jelly cervix 5mL intrauterine normal saline prior SIS . Demographic data collect patient . Blinding The test gel ( 2 % lidocaine gel ) KY jelly colourless . They prepare research nurse label . The study syringe contain test solution ( lidocaine normal saline ) also prepare research nurse . Lidocaine normal saline identical appearance ( i.e. , clear colourless solution ) contain identical 5-mL disposable syrinx label number . The patient physician know group allocation test gel test solution give . Only research nurse responsible preparation know gel/solution , involve patient care , procedure assessment pain level . The procedure Before SIS , sterile bivalve speculum introduce vagina visualization cervix . The cervix vagina cleanse antiseptic solution . 3mL test gel ( 2 % lidocaine gel KY jelly ) apply surface cervix use gauze accord group allocation . An infant feeding tube insert uterine cavity endocervical canal . Test solution ( 2 % lidocaine 5mL normal saline 5mL ) instill uterine cavity infant feeding tube accord group allocation : A ) Lidocaine gel group : subject receive local application 2 % lidocaine gel 3mL cervix ( study drug ) intrauterine infusion normal saline 5mL ( placebo ) . B ) Intrauterine lidocaine group : subject receive local application KY jelly 3mL cervix ( placebo ) intrauterine infusion 2 % lidocaine 5mL ( study drug ) . C ) Placebo group : subject receive local application KY jelly 3mL cervix intrauterine infusion normal saline 5mL ( double placebo ) . The speculum remove . After five minute , transvaginal ultrasound probe insert vagina 5 10 mL sterile saline solution instill uterine cavity . The volume normal saline use depend distension uterine cavity , provide clear visualization uterine cavity . After ultrasound examination , transvaginal probe infant feed tube remove , procedure complete . Assessment pain level Patients ask rate pain level procedure visual analogue scale ( VAS ) , mark `` X '' 10-cm line ( 0cm : pain , 10cm : unbearable pain ) . Ratings do different time : 1. speculum insertion 2. test solution ( lidocaine placebo ) instillation 3. normal saline infusion 4. immediately procedure 5 . 20 minute procedure 6 . Overall pain score throughout procedure The physician also record score visible sign woman 's distress procedure ( moan , body movement , grab table , express pain ) use 3-point observer scale parameter 0 response , 1 mild response , 2 severe response . If patient require additional analgesic , oral mefenamic acid 500 mg would give record . Data collection Apart assessment pain level , also record patient characteristic include age , parity , ethnicity , history chronic pelvic pain , history dysmenorrhea , prior curettage , menopausal status , education , socioeconomic status , indication SIS , use tenaculum , volume saline solution infusion presence uterine pathology . Any need additional analgesic side effect experience subject record . Blood pressure pulse measure recorded procedure . Follow-up No routine follow-up visit arrange solely study unless consider necessary investigator . Assessment outcome : The primary outcome pain level SIS procedure assess visual analog scale . Other outcome measure include patient ' distress , immediately procedure evaluate physician 3-point observer scale , need additional analgesic side effect experience patient . Assessment safety : SIS well-established procedure detect abnormality uterus endometrial cavity . It safe procedure . It may cause cramping , spot vaginal discharge . Some woman may experience severe pain cramping . Pelvic infection occur less 1 % . Lidocaine commonly use anaesthetic agent . Local application cervix intrauterine use lidocaine various gynaecological procedure evaluate several study severe side effect report .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Women age 18 year old schedule saline infusion sonohysterography History cervical stenosis Known allergy lidocaine Pregnancy Acute cervicitis Profuse vaginal bleeding Consumption pain killer day procedure</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>saline infusion sonohysterography</keyword>
</DOC>